Bill
Bill > HB3414
OK HB3414
OK HB3414Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities.
summary
Introduced
02/07/2022
02/07/2022
In Committee
04/11/2022
04/11/2022
Crossed Over
03/08/2022
03/08/2022
Passed
Dead
05/27/2022
05/27/2022
Introduced Session
2022 Regular Session
Bill Summary
An Act relating to public health and safety; authorizing certain governmental entities to conduct research or medical trials related to psilocybin and psilocin; specifying certain medical conditions for which research or clinical trials authorized; authorizing universities or institutions of higher education to enter into memoranda of agreement; imposing requirements with respect to studies; requiring registration with the Oklahoma State Department of Health; requiring license; prescribing requirements for registration information; providing for nonrefundable fee; specifying fee amount; providing for duration of registration; requiring additional registration with the Oklahoma Department of Agriculture, Food, and Forestry; prescribing content of registration; authorizing nonrefundable fee; prescribing fee amount; requiring administrative rules; providing immunity for certain persons conducting activity pursuant to valid license; providing for written certifications; prescribing content thereof; providing for expiration of certifications; providing immunity to certain persons for participation in clinical trials; providing for certain quantities of substance as basis for immunity; providing for applicability of Uniform Controlled Dangerous Substances Act; providing for assertion of affirmative defense; providing for effect of registrations; requiring written reports; imposing deadline; providing for confidentiality of certain personal information; requiring enumerated agencies to maintain confidentiality with respect to information; and providing for codification.
AI Summary
This bill authorizes certain government entities, universities, and research facilities in Oklahoma to conduct research and clinical trials on the use of psilocybin and psilocin (the active compounds in "magic mushrooms") for palliative care, end-of-life care, and the treatment of various medical conditions such as PTSD, treatment-resistant depression, and chronic pain. The bill requires these entities to register with the Oklahoma State Department of Health and the Oklahoma Department of Agriculture, Food, and Forestry, and imposes certain requirements and fees for the registration process. The bill also provides immunity from arrest, prosecution, and penalties for researchers, physicians, and patients participating in the authorized clinical trials, as long as they comply with the provisions of the law. Additionally, the bill amends the Uniform Controlled Dangerous Substances Act to include a registration category and fee for researchers of psilocybin or psilocin.
Committee Categories
Health and Social Services
Sponsors (17)
Daniel Pae (R)*,
Lonnie Paxton (R)*,
Denise Brewer (D),
Dean Davis (R),
Eddy Dempsey (R),
Mickey Dollens (D),
Jon Echols (R),
Justin Humphrey (R),
Robert Manger (R),
Ryan Martinez (R),
Kevin McDugle (R),
Marcus McEntire (R),
Cyndi Munson (D),
Logan Phillips (R),
Jacob Rosecrants (D),
John Talley (R),
Collin Walke (D),
Last Action
Coauthored by Representative Pae (on 04/14/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...